Variant report
Variant | nsv520893 |
---|---|
Chromosome Location | chr7:110181022-110184313 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10238549 | chr7:110181022-110181023 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs386716816 | chr7:110181077-110181078 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568135113 | chr7:110181111-110181112 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs373536248 | chr7:110181144-110181145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148470812 | chr7:110181211-110181212 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575940598 | chr7:110181277-110181278 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs575793576 | chr7:110181282-110181283 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs13237799 | chr7:110181324-110181325 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs557837373 | chr7:110181353-110181354 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554084625 | chr7:110181360-110181361 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544592516 | chr7:110181425-110181426 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191512900 | chr7:110181432-110181433 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540252704 | chr7:110181442-110181443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs559981779 | chr7:110181456-110181457 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545461726 | chr7:110181465-110181466 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs35083525 | chr7:110181474-110181475 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs542585263 | chr7:110181475-110181476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs562700550 | chr7:110181507-110181508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs76634221 | chr7:110181527-110181528 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563773132 | chr7:110181548-110181549 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547091875 | chr7:110181549-110181550 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571371085 | chr7:110181592-110181593 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs527254140 | chr7:110181611-110181612 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs547398358 | chr7:110181649-110181650 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565294862 | chr7:110181724-110181725 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567176626 | chr7:110181742-110181743 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs536140806 | chr7:110181755-110181756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs539060746 | chr7:110181783-110181784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs555825373 | chr7:110181851-110181852 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs55757343 | chr7:110181886-110181887 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs56378419 | chr7:110181887-110181888 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs183340913 | chr7:110181899-110181900 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs558797358 | chr7:110181910-110181911 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs577916268 | chr7:110181914-110181915 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs79758968 | chr7:110181915-110181916 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs142518422 | chr7:110181916-110181917 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs150631277 | chr7:110181931-110181932 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs200077334 | chr7:110181933-110181934 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs532238570 | chr7:110181934-110181935 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs74501953 | chr7:110181937-110181938 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs550572280 | chr7:110181938-110181939 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs367931794 | chr7:110181968-110181969 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs374086010 | chr7:110181970-110181971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs377314753 | chr7:110181971-110181972 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs369894398 | chr7:110181973-110181974 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs373802550 | chr7:110181974-110181975 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs577146709 | chr7:110182031-110182032 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs577731319 | chr7:110182033-110182034 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs150501969 | chr7:110182043-110182044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs553728778 | chr7:110182048-110182049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 16397240 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Autism | 19401682 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:110175200-110182600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
2 | chr7:110175200-110188400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr7:110180400-110183200 | Enhancers | HMEC | breast |
4 | chr7:110180800-110182600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr7:110181000-110184600 | Enhancers | NHEK | skin |
6 | chr7:110181400-110183200 | Enhancers | NHLF | lung |
7 | chr7:110182000-110182600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr7:110182600-110182800 | Enhancers | NH-A | brain |
9 | chr7:110182600-110183200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
10 | chr7:110182600-110184200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
11 | chr7:110182600-110185200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
12 | chr7:110182800-110183000 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
13 | chr7:110182800-110183800 | Weak transcription | NH-A | brain |
14 | chr7:110183000-110188200 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
15 | chr7:110183200-110183600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
16 | chr7:110183200-110183800 | Weak transcription | HMEC | breast |
17 | chr7:110183200-110184000 | Weak transcription | NHLF | lung |
18 | chr7:110183600-110185200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
19 | chr7:110183800-110184200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
20 | chr7:110183800-110184400 | Enhancers | HMEC | breast |
21 | chr7:110183800-110184400 | Enhancers | NH-A | brain |
22 | chr7:110184000-110184200 | Enhancers | NHLF | lung |
23 | chr7:110184200-110184600 | Enhancers | Fetal Stomach | stomach |
24 | chr7:110184200-110188000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |